Chen Bai

Chen Bai


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YZYue Zhang
Yue Zhang
MLMengqi Luo
Mengqi Luo
PWPeng Wu
Peng Wu
SWSong Wu
Song Wu
TLTzong-Yi Lee
Tzong-Yi Lee
CBChen Bai
Chen Bai
Traditional drug design requires a great amount of research time and developmental expense. Booming computational approaches, including computational biology, computer-aided drug design, and artificial intelligence, have the potential to expedite the efficiency of drug discovery by minimizing the time and financial cost. In recent years, computational approaches are being widely used to improve the efficacy and effectiveness of drug discovery and pipeline, leading to the approval of plenty of new drugs for marketing. The present review emphasizes on the applications of these indispensable computational approaches in aiding target identification, lead discovery, and lead optimization. Some challenges of using these approaches for drug design are also discussed. Moreover, we propose a methodology for integrating various computational techniques into new drug discovery and design.

17 June 2020 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
CBChen Bai
Chen Bai
AWArieh Warshel
Arieh Warshel

14 October 2021 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CBChen Bai
Chen Bai
JWJunlin Wang
Junlin Wang
GCGeng Chen
Geng Chen
HZHonghui Zhang
Honghui Zhang
Ke AnKe An
Ke An
AWArieh Warshel
Arieh Warshel

13 July 2021 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CBChen Bai
Chen Bai
JWJunlin Wang
Junlin Wang
DMDibyendu Mondal
Dibyendu Mondal
YDYang Du
Yang Du
RYRichard Ye
Richard Ye
AWArieh Warshel
Arieh Warshel

27 March 2024 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
PWPeng Wu
Peng Wu
HDHuabin Du
Huabin Du
YYYingchao Yan
Yingchao Yan
TLTzong-Yi Lee
Tzong-Yi Lee
CBChen Bai
Chen Bai
SWSong Wu
Song Wu
Molecular generative models have exhibited promising capabilities in designing molecules from scratch with high binding affinities in a predetermined protein pocket, offering potential synergies with traditional structural-based drug design strategy. However, the generative processes of such models are random and the atomic interaction information between ligand and protein are ignored. On the other hand, the ligand has high propensity to bind with residues called hotspots. Hotspot residues contribute to the majority of the binding free energies and have been recognized as appealing targets for designed molecules. In this work, we develop an interaction prompt guided diffusion model, InterDiff to deal with the challenges. Four kinds of atomic interactions are involved in our model and represented as learnable vector embeddings. These embeddings serve as conditions for individual residue to guide the molecular generative process. Comprehensive in silico experiments evince that our model could generate molecules with desired ligand–protein interactions in a guidable way. Furthermore, we validate InterDiff on two realistic protein-based therapeutic agents. Results show that InterDiff could generate molecules with better or similar binding mode compared to known targeted drugs.

13 May 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
XZXiaohong Zhu
Xiaohong Zhu
MLMengqi Luo
Mengqi Luo
KAKe An
Ke An
DSDanfeng Shi
Danfeng Shi
THTingjun Hou
Tingjun Hou
CBChen Bai
Chen Bai
Homomeric dimerization of metabotropic glutamate receptors (mGlus) is essential for the modulation of their functions and represents a promising avenue for the development of novel therapeutic approaches to address central nervous system diseases. Yet, the scarcity of detailed molecular and energetic data on mGlu2 impedes our in-depth comprehension of their activation process. Here, we employ computational simulation methods to elucidate the activation process and key events associated with the mGlu2, including a detailed analysis of its conformational transitions, the binding of agonists, G i protein coupling, and the guanosine diphosphate (GDP) release. Our results demonstrate that the activation of mGlu2 is a stepwise process and several energy barriers need to be overcome. Moreover, we also identify the rate-determining step of the mGlu2’s transition from the agonist-bound state to its active state. From the perspective of free-energy analysis, we find that the conformational dynamics of mGlu2’s subunit follow coupled rather than discrete, independent actions. Asymmetric dimerization is critical for receptor activation. Our calculation results are consistent with the observation of cross-linking and fluorescent-labeled blot experiments, thus illustrating the reliability of our calculations. Besides, we also identify potential key residues in the G i protein binding position on mGlu2, mGlu2 dimer’s TM6–TM6 interface, and Gi α5 helix by the change of energy barriers after mutation. The implications of our findings could lead to a more comprehensive grasp of class C G protein-coupled receptor activation.